Price (delayed)
$24.99
Market cap
$369.77M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$5.07
Enterprise value
$332.74M
Anika Therapeutics, Inc. is a global joint preservation company that creates and delivers meaningful advancements in early intervention orthopedic care. Anika Therapeutics partners with clinicians to understand what they need
There are no recent dividends present for ANIK.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.